SCHEMBL24372550

SCHEMBL24372550

O=C(CS)OCc1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.53
CYP2C9 P11712 2/20 0.53
CYP2C19 P33261 2/20 0.53
ALDH1A1 P00352 5/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
HPGD P15428 4/20 0.47
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
TP53 P04637 2/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 1/20 0.47
ENPP2 Q13822 1/20 0.45
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
KDM4E B2RXH2 5/20 0.42
NPY1R P25929 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24372533 0.89 ALDH1A1 (0.55) CYP1A2CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL24372549 0.83 LMNA (0.47) ALDH1A1KMT2AMEN1MAPTSMN1; SMN2
SCHEMBL498454 0.82 ALDH1A1 (0.68) CYP1A2CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL24372557 0.81 MGLL (0.44) TDP1LMNA
SCHEMBL24372545 0.81 ALDH1A1 (0.46) CYP1A2CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL11307628 0.80 ALDH1A1 (0.66) CYP1A2CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL20258860 0.78 KMT2A (0.69) CYP2C9CYP2C19ALDH1A1L3MBTL1KMT2A
SCHEMBL11137258 0.77 ALDH1A1 (0.61) CYP1A2CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL25527470 0.77 FOLH1 (0.49) ALDH1A1MAPK1L3MBTL1KMT2AMEN1
SCHEMBL21993645 0.76 ALDH1A1 (0.51) ALDH1A1MAPK1L3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127286-A1 LIGANDS FOR NANO-SIZED MATERIALS MERCK PATENT GMBH (DE) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127286-A1 LIGANDS FOR NANO-SIZED MATERIALS L1CAM, EPCAM, SELPLG CYP1A2 3581/4885CYP2C9 3260/4885CYP2C19 3474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.